Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential treatment for COVID‐19?

Eitemau Tebyg

• What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
  gan: Goren, Andy, et al.
  Cyhoeddwyd: (2020)
• Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
  gan: Wambier, Carlos Gustavo, et al.
  Cyhoeddwyd: (2020)
• Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
  gan: Goren, Andy, et al.
  Cyhoeddwyd: (2021)
• Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
  gan: Wambier, Carlos Gustavo, et al.
  Cyhoeddwyd: (2020)
• Androgen sensitivity gateway to COVID‐19 disease severity
  gan: Wambier, Carlos Gustavo, et al.
  Cyhoeddwyd: (2020)